Hiv And Aids
BRIDGEWATER, N.J. - A division of Johnson & Johnson said Wednesday that federal regulators granted full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.
MARIETTA, Pa. - Malaria. Tuberculosis. Alzheimer's disease.